Loading
VP
Vitae Pharmaceuticals, Inc Stock: price and insider trades · United States
Vitae Pharmaceuticals, Inc: what insiders have been doing
This page follows insider dealings at Vitae Pharmaceuticals, Inc as filed with SEC (Form 4). Nothing new has been filed by managers of Vitae Pharmaceuticals, Inc in twelve months, the latest record being from 25 October 2016.
The full history, which starts in 2016, counts no purchases against 3 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
20
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€20M
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 25 October 2016
Declarations20 total
11,002 shares@ US$21.0041.0% of flowCommon StockSEC:0001104659-16-151947:0
15,830 shares@ US$21.0059.0% of flowCommon StockSEC:0001104659-16-151947:1
244,996 shares@ US$21.0083.6% of flowCommon StockSEC:0001104659-16-151945:0
228,274 shares@ US$21.0087.9% of flowCommon StockSEC:0001104659-16-151956:0
13,233 shares@ US$21.0095.8% of flowCommon StockSEC:0001104659-16-151941:0
828 shares@ US$21.0078.2% of flowCommon StockSEC:0001104659-16-151938:0
87,301 shares@ US$3.916.2% of flowCommon StockSEC:0001104659-16-151388:0
29,657 shares@ US$7.133.8% of flowCommon StockSEC:0001104659-16-151388:1
6,944 shares@ US$14.401.8% of flowCommon StockSEC:0001104659-16-151388:2
1,025,000 shares@ US$20.85100.0% of flowCommon Stock, par value $0.0001 ("Common Stock")SEC:0000902664-16-008155:0
50,000 shares@ US$20.8116.3% of flowCommon StockSEC:0001104659-16-145191:0
747 shares@ US$6.110.1% of flowCommon StockSEC:0001104659-16-140285:0
2,100 shares@ US$6.110.2% of flowCommon StockSEC:0001104659-16-140287:0
828 shares@ US$6.1121.8% of flowCommon StockSEC:0001104659-16-140286:0
2,086 shares@ US$6.114.2% of flowCommon StockSEC:0001104659-16-140288:0
1,935 shares@ US$3.453.8% of flowCommon StockSEC:0001104659-16-106698:0
14,195 shares@ US$3.4527.9% of flowCommon StockSEC:0001104659-16-106698:1
16,130 shares@ US$7.4268.3% of flowCommon StockSEC:0001104659-16-106698:2
15,000 sharesCommon StockSEC:0001104659-16-091217:0
26,537 sharesCommon StockSEC:0001104659-16-091215:0
20 of 20 declarations
About Vitae Pharmaceuticals, Inc
Vitae Pharmaceuticals, Inc is a biopharmaceutical company focused on developing treatments for genetic diseases and metabolic disorders. It is listed on NASDAQ under the ticker symbol VTAE.
